Stephanie Goggin, OD
Optometrist · Edwardsville, ILNPI 1013965367
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (56.6%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. Coopervision Inc. accounts for 62.3% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2021 at $1,876 and has fallen 75.4% since, to $461 in 2025. Among optometrist clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 154 payments — averaging $38.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Coopervision Inc.$4K
- Johnson & Johnson Vision Care, Inc.$796
- Tarsus Pharmaceuticals, Inc.$171
- Bausch & Lomb Americas Inc.$171
- Novartis$168
- Alcon$139
- plus $777 from 9 others
What the payments were for
- Consulting fees$972%
- Speaking & faculty fees$3,33257%
- Food & beverage$2,42641%
- Entertainment$351%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Coopervision Inc. | 26 | $3,668 |
| Johnson & Johnson Vision Care, Inc. | 64 | $796 |
| Tarsus Pharmaceuticals, Inc. | 7 | $171 |
| Bausch & Lomb Americas Inc. | 6 | $171 |
| Novartis | 8 | $168 |
| Alcon | 7 | $139 |
| Mallinckrodt Hospital Products Inc. | 5 | $135 |
| Eyevance Pharmaceuticals LLC | 8 | $129 |
| Sun Pharmaceutical Industries Inc. | 5 | $126 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 2 | $113 |
| AbbVie(2 entities) | 5 | $85 |
| Oyster Point Pharma, Inc. | 3 | $67 |
| Biotissue Holdings Inc. | 5 | $45 |
| Shire North American Group Inc | 2 | $40 |
| Optos, Inc. | 1 | $35 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Non-Product Brand Specific$1,666
- BTOD$105
How this compares
$5,890 in reported general payments places this provider in the 95th percentile of 2,257 optometrist providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Latanoprost | 39 | $379 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 13 | $134 |
| Timolol Maleate | 14 | $109 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Edwardsville
- Pamela LoweChicago$447K
- Jeffrey LewisChampaign$394K
- Adeyinka AdewaleGodfrey$391K
- Michael ChaglasianChicago$367K
- Jessilin QuintChicago$366K
- Jullian CerasuoloChicago$329K
- Steven EidenDeerfield$259K
- Peter KehoeGalesburg$167K
- Gulroop HansraDowners Grove$151K
- Treacy AdamoHinsdale$94K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.